LU77764A1 - - Google Patents

Info

Publication number
LU77764A1
LU77764A1 LU77764A LU77764A LU77764A1 LU 77764 A1 LU77764 A1 LU 77764A1 LU 77764 A LU77764 A LU 77764A LU 77764 A LU77764 A LU 77764A LU 77764 A1 LU77764 A1 LU 77764A1
Authority
LU
Luxembourg
Application number
LU77764A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU77764A1 publication Critical patent/LU77764A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
LU77764A 1976-07-16 1977-07-14 LU77764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
LU77764A1 true LU77764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-02-02

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
LU77764A LU77764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-16 1977-07-14

Country Status (29)

Country Link
US (1) US4080454A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5337673A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR213652A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT351561B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE856710A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1061788A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH622512A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS212264B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD131556A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2731736A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK139029B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EG (1) EG12762A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES460686A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI772183A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2358399A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1542178A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR68686B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU177713B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL52409A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU77764A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7707729A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO772489L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH13190A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL103783B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT66808B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE421125B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU673169A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (1) YU171677A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA773927B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
ATE533488T1 (de) * 2005-08-22 2011-12-15 Melior Pharmaceuticals I Inc Verfahren und formulierungen zur modulierung von lyn-kinaseaktivität und behandlung assoziierter erkrankungen
JP2010518860A (ja) * 2007-02-20 2010-06-03 メリオール・ファーマスーティカルズ・ワン・インコーポレイテッド Lynキナーゼの活性化剤の同定方法
AU2008279242A1 (en) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Methods of activating IRS-1 and AKT
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
US20130158055A1 (en) 2010-05-28 2013-06-20 Andrew G. Reaume Prevention Of Pancreatic Beta Cell Degeneration
CA3059432A1 (en) 2017-04-10 2018-10-18 Melior Pharmaceuticals I, Inc. Compositions comprising a lyn kinase activator and a trpms agonist
EP3755334A4 (en) 2018-02-21 2022-03-23 Melior Pharmaceuticals I, Inc. TREATMENT OF LIVER DISEASES

Also Published As

Publication number Publication date
SE421125B (sv) 1981-11-30
SE7707471L (sv) 1978-01-17
PH13190A (en) 1980-01-16
EG12762A (en) 1979-12-31
IL52409A0 (en) 1977-08-31
GR68686B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-02-01
PT66808B (en) 1978-12-21
FR2358399B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-10-17
CS212264B2 (en) 1982-03-26
DK139029C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-05-07
BE856710A (fr) 1978-01-11
AR213652A1 (es) 1979-02-28
JPS5512017B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-03-29
US4080454A (en) 1978-03-21
ZA773927B (en) 1978-05-30
IL52409A (en) 1979-11-30
ES460686A1 (es) 1978-12-01
ATA509277A (de) 1979-01-15
HU177713B (en) 1981-12-28
FR2358399A1 (fr) 1978-02-10
AU2663877A (en) 1978-05-18
DE2731736A1 (de) 1978-01-26
DD131556A5 (de) 1978-07-05
PT66808A (en) 1977-08-01
NL7707729A (nl) 1978-01-18
GB1542178A (en) 1979-03-14
CA1061788A (en) 1979-09-04
DK318177A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-17
DK139029B (da) 1978-12-04
PL199633A1 (pl) 1978-04-10
NO772489L (no) 1978-01-17
YU171677A (en) 1982-06-30
PL103783B1 (pl) 1979-07-31
AT351561B (de) 1979-08-10
SU673169A3 (ru) 1979-07-05
CH622512A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-04-15
FI772183A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1978-01-17
JPS5337673A (en) 1978-04-06

Similar Documents

Publication Publication Date Title
DE2727193C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK142046C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK141526C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK139108C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2612210C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK139029C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK248677A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5373054U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2624377C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5543132Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK55176A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS52165582U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE2745891B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5711872Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5710087Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5620836Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5549320Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5614792Y2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI51794B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI53035C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5629770B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5370990U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK217576A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS52171891U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JPS5374961U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)